The National Institutes of Health (NIH) is offering Small Business Technology Transfer (STTR) grants for the development of direct mRNA-based and self-amplifying mRNA-based HIV envelope vaccine platforms. This grant aims to support Small Business Concerns (SBCs) and non-profit research institutions in creating innovative technologies with commercial potential for clinical research purposes. The closing date for applications is April 5, 2019.
Opportunity ID: 283151
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PA-16-208 |
Funding Opportunity Title: | The Use of mRNA for an HIV Envelope Vaccine (R41/R42) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 19, 2016 |
Last Updated Date: | – |
Original Closing Date for Applications: | Apr 05, 2019 |
Current Closing Date for Applications: | Apr 05, 2019 |
Archive Date: | May 06, 2019 |
Estimated Total Program Funding: | – |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Technology Transfer (STTR) grant applications from Small Business Concerns (SBCs) and non-profit research institutions including academic partners that will focus on the development of novel direct mRNA-based and self-amplifying mRNA-based HIV envelope vaccine platforms suitable for use in clinical research. Such technologies should have commercial potential. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-16-208.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-D | Use for due dates on or before January 24, 2018 | PKG00222931 | Aug 05, 2016 | Jan 24, 2018 | View | |
FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236965 | Dec 11, 2017 | Apr 05, 2019 | View |
Package 1
Mandatory forms
283151 RR_SF424_2_0-2.0.pdf
283151 PHS398_CoverPageSupplement_3_0-3.0.pdf
283151 RR_OtherProjectInfo_1_3-1.3.pdf
283151 PerformanceSite_2_0-2.0.pdf
283151 RR_KeyPersonExpanded_2_0-2.0.pdf
283151 RR_Budget_1_3-1.3.pdf
283151 RR_SubawardBudget30_1_3-1.3.pdf
283151 PHS398_ResearchPlan_3_0-3.0.pdf
283151 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
283151 PHS_Inclusion_Enrollment_Report-1.0.pdf
283151 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
283151 RR_SF424_2_0-2.0.pdf
283151 PHS398_CoverPageSupplement_4_0-4.0.pdf
283151 RR_OtherProjectInfo_1_4-1.4.pdf
283151 PerformanceSite_2_0-2.0.pdf
283151 RR_KeyPersonExpanded_2_0-2.0.pdf
283151 RR_Budget_1_4-1.4.pdf
283151 RR_SubawardBudget30_1_4-1.4.pdf
283151 PHS398_ResearchPlan_4_0-4.0.pdf
283151 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
283151 PHS_AssignmentRequestForm_2_0-2.0.pdf